Shanghai Jiaoda Onlly Co.,Ltd (SHA:600530)
5.43
+0.26 (5.03%)
Apr 30, 2026, 3:00 PM CST
SHA:600530 Revenue
In the year 2025, Shanghai Jiaoda Onlly Co.,Ltd had annual revenue of 314.12M CNY, down -3.40%. Shanghai Jiaoda Onlly Co.,Ltd had revenue of 89.66M in the quarter ending December 31, 2025, with 1.55% growth.
Revenue
314.12M
Revenue Growth
-3.40%
P/S Ratio
12.75
Revenue / Employee
344.42K
Employees
912
Market Cap
4.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 314.12M | -11.07M | -3.40% |
| Dec 31, 2024 | 325.18M | 28.85M | 9.74% |
| Dec 31, 2023 | 296.33M | -80.82M | -21.43% |
| Dec 31, 2022 | 377.15M | 14.57M | 4.02% |
| Dec 31, 2021 | 362.58M | 29.88M | 8.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.76B |
| Huaren Pharmaceutical | 1.33B |
| PKU HealthCare Corp.,Ltd. | 1.20B |
| LanZhou Foci Pharmaceutical | 915.53M |
| Shandong Wohua Pharmaceutical | 818.16M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Qianjiang Yongan Pharmaceutical | 783.17M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |